Cargando…
Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage
INTRODUCTION: The risk and benefit of restarting oral anticoagulation (OAC) therapy among patients with atrial fibrillation or flutter (AF) and an episode of anticoagulation-associated intracerebral hemorrhage (ICH) remain unclear. Whether or not to resume OAC after an OAC-associated ICH will remain...
Autores principales: | Sadighi, Alireza, Wasko, Lisa, DiCristina, Heather, Wagner, Thomas, Wright, Kathryn, Capone, Kellie, Monczewski, Maureen, Kester, Margaret, Bourdages, George, Griessenauer, Christoph, Zand, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037578/ https://www.ncbi.nlm.nih.gov/pubmed/32123759 http://dx.doi.org/10.1016/j.ensci.2020.100222 |
Ejemplares similares
-
Anticoagulation Resumption After Intracerebral Hemorrhage
por: Li, Yan-guang, et al.
Publicado: (2018) -
Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021) -
Modeling Intracerebral Hemorrhage Growth and Response to Anticoagulation
por: Greenberg, Charles H., et al.
Publicado: (2012) -
Outcome of intracerebral hemorrhage associated with different oral anticoagulants
por: Wilson, Duncan, et al.
Publicado: (2017) -
Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
por: Kuramatsu, Joji B., et al.
Publicado: (2019)